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Abstract
Mobile HIV counseling and testing (mHCT) is an effective tool to access hard-to-reach most-at-
risk populations (MARPs), but identifying which populations are not accessing services is often a 
challenge. We compared correlates of HIV infection and awareness of HIV care services among 
populations tested through mHCT and at testing facilities in Nigeria. Participants in a cross-
sectional study completed a questionnaire and HIV counseling and testing between May 2005 and 
March 2010. Of 27,586 total participants, 26.7% had been previously tested for HIV; among 
mHCT clients, 14.7% had previously tested. HIV prevalence ranged from 6.6% among those 
tested through a facility to 50.4% among brothel-based sex workers tested by mHCT. Among 
mHCT participants aged 18–24, women were 9.0 times more likely to be infected than men. 
Women aged 18–24 were also less likely than their male counterparts to know that there were 
medicines available to treat HIV (63.2% vs. 68.1%; p=0.03). After controlling for gender, age and 
other risk factors, those with current genital ulcer disease were more likely to be HIV-infected 
(ORmHCT=1.65, 1.31–2.09; ORfacility=1.71, 1.37–2.14), while those previously tested were less 
likely to be HIV-infected (ORmHCT=0.75, 0.64–0.88; ORfacility=0.27, 0.24–0.31). There is an 
urgent need to promote strategies to identify those who are HIV-infected within MARPs, 
particularly young women, and to educate and inform them about availability of HIV testing and 
care services. mHCT, ideally coupled with STI management, may help to ensure that MARPs 
access HIV prevention support, and if infected, access care and treatment.
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INTRODUCTION
In Nigeria, 2.98 million people are estimated to be living with human immunodeficiency 
virus (HIV), second only to South Africa (UNAIDS., 2010). Since it was first reported, the 
HIV prevalence has continued to increase from less than 0.1% in 1987 to 5.8% in 2001, with 
a decrease to a plateau in 2005 to 4.4% (FMOH., 2004, 2007). Although Nigeria’s HIV/
AIDS prevalence is still relatively low compared to some countries in sub-Saharan Africa, 
the country stands at a critical point in its epidemic where increased prevention and 
treatment efforts today could help avert a much more significant epidemic in the future. The 
HIV epidemic in Nigeria is now classified as a mixed epidemic with the burden of disease 
greater among certain high-risk groups (FMOH., 2007). As the most populous country in 
Africa and one of the most populous nations in the world, even a small increase in the HIV/
AIDS prevalence rate in Nigeria would represent a significant threat to the global HIV/AIDS 
burden.
HIV counseling and testing (HCT) strategies serve as important tools for identifying HIV-
infected persons, a necessary first step in accessing HIV care (Obermeyer & Osborn, 2007). 
HCT is now being offered in various settings, including sexually transmitted infection (STI) 
clinics and general outpatient clinics, as well as in field settings by mobile testing teams. 
Despite the importance of HCT, access and uptake can remain quite low (deGraft-Johnson, 
Paz-Soldan, Kasote, & Tsui, 2005; Fylkesnes & Siziya, 2004; Obermeyer & Osborn, 2007), 
particularly in rural areas (Bwambale, Ssali, Byaruhanga, Kalyango, & Karamagi, 2008; 
Wringe et al., 2008) and among MARPs(Dandona et al., 2005; Kayembe et al., 2008; Todd 
et al., 2007) for whom regular interaction with the health care system may be rare. Many 
factors have been associated with low uptake, including low perceived risk of HIV infection, 
the lack of resources necessary to provide HCT at all sites with identified need, the hours 
and the location of HCT services, the remote geographic location of those in need, and the 
intense stigma associated with HIV that leads to ambivalence toward HIV testing 
(Bwambale, et al., 2008; deGraft-Johnson, et al., 2005; Fylkesnes & Siziya, 2004; 
Obermeyer & Osborn, 2007; Wringe, et al., 2008). Mobile HCT (mHCT) is a strategy for 
overcoming many of the practical barriers to accessing HCT services, especially for hard-to-
reach groups.
We present HIV prevalence and awareness of HIV care and treatment services among 
different risk populations which accessed mHCT services that provided free rapid HIV 
testing in both rural and high-density communities in Nigeria from May 2005 through 
March 2010. We compare these data to those collected from facility-based HCT during the 
same period.
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METHODS
Adults 18 years or older provided study informed consent and volunteered for HCT. 
Facility-based HCT was conducted at Asokoro District Hospital, Nyanya Hospital, and 
Gwagwalada Specialist Hospital in the Federal Capital Territory. Facility-based HCT was 
provided to the following groups: antenatal clinic (ANC) attendees; general outpatient 
department patients, including patients presenting with STI symptoms; patients who 
requested voluntary counseling and testing (VCT) at the hospital; and negative partners in 
serodiscordant couples (DC) whose HIV-infected partners were receiving care at the 
hospital.
Mobile HCT was performed by a team of staff based at Asokoro District Hospital and was 
conducted in Niger, Kaduna, Nassarawa, and Benue States and the Federal Capital Territory. 
Mobile HCT targeted several MARPs including brothel-based sex workers, non-brothel-
based sex workers, motorcycle taxi drivers, and individuals living in the communities 
proximal to these groups [i.e., outreach community testing (OCT)]. To identify underserved, 
high-prevalence areas, visits to the location were conducted to identify key informants who 
provided insight into community needs for HCT and to establish a link with the community 
leaders. The community leaders and key informants then helped identify other locations 
without access to HCT services. Identified communities were then approached by a field 
manager who set a mutually agreed upon date and location where mobile testing would take 
place. On the testing day, counselors approached individuals within and surrounding the 
community. A general health talk was given by a counselor, describing both the study and 
the HCT process. Individuals who expressed interest in participating were assigned a 
counselor who conducted informed consent for both HIV testing and participation in the 
screening phase of the study. Individuals who did not want to participate in the study were in 
majority those who did not want to be tested by a mobile unit and were referred to offered 
standard facility-based HCT. The mHCT team for the study consisted of a driver/outreach 
worker, four HIV counselors, and a laboratory technician. Educational materials and 
condoms were provided in the field.
The rapid HIV testing algorithm in Nigeria varied over the course of the study. From May 
2005 to July 2006, two rapid HIV tests, the Capillus HIV-1/HIV-2 (Cambridge Diagnostic, 
Ireland) and Genie II HIV-1/HIV-2 (Bio-Rad, France) tests, were performed serially to 
confirm reactive results, with discordant results resolved by a third tiebreaker rapid HIV test, 
the Determine HIV-1/2 (Inverness Medical Diagnostics, USA). During this period, rapid 
testing could not be conducted in the field because the Capillus and Genie tests are required 
to be kept refrigerated until use, and temperatures in the field exceeded the acceptable range 
according to the package inserts. Instead, samples were collected in the field, tested at the 
Asokoro Hospital, and results were returned in field sites 2 weeks later with post-test 
counseling. From August 2006 to March 2010, the Determine HIV-1/2 and Stat-Pak HIV-1/2 
(Chembio Diagnostics, USA) tests were run simultaneously in the mobile van laboratory. 
Blood samples that were concordantly reactive or non-reactive by the two rapid tests were 
considered to be true-positive or true-negative, respectively. Post-test counseling was 
conducted within 45 minutes of sample collection. Samples with discordant results were 
retested and resolved using the Genie II test.
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The study questionnaires were administered before testing and collected information on 
demographics, history of HIV testing, condom use during the last sexual intercourse, 
reported sexual behaviors, and history or current symptoms of STI. Questionnaires on HIV 
knowledge, risk perception, awareness about HIV care services, and beliefs in traditional 
medicine were implemented in March 2007. Awareness of HIV care services and benefits 
included questions (Yes/No) on knowing that there are medicines to treat HIV and agreeing 
that medicines to treat HIV/AIDS: (1) help people with HIV to live longer, (2) always 
prevent death, (3) are free, and (4) are easy to get.
Demographic characteristics and reported risk behaviors were examined as correlates of 
HIV status, controlling for gender, and risk population using chi-square tests. Changes in 
HIV prevalence with increasing age were modeled, by gender and site type (mHCT versus 
facility-based) using non-linear regression. The associations between HIV infection and 
demographic factors by risk populations were evaluated using odds ratios (OR). Factors 
associated at the p<0.05 level with HIV infection were then evaluated in multivariate logistic 
regression. To control for confounding, variables that alter any significant odds ratios by ≥ 
20% were retained. Responses to HIV knowledge, awareness and risk perception questions 
were summarized by gender, risk group, and whether clients received mobile or facility-
based HCT.
Institutional Review Boards at the University of Maryland Baltimore, the CDC, and the 
FMOH’s National Institute for Pharmaceutical Research and Development approved the 
study protocol.
RESULTS
Of 27,949 enrolled and screened, 363 (1.3%) had missing HIV test results or risk population 
designations and were excluded from the analyses. Of 27,586 individuals with HIV test 
results, 37.6% were male and 26.7% of participants reported having had a blood test for the 
AIDS (HIV) virus (Table 1). The proportion with a prior HIV test was higher among those 
who received facility-based testing than mHCT (34.6% vs. 14.7%, p=0.0001). Only 14.8% 
of sex workers reported having had an HIV test.
Overall, 15.2% of participants reported using a condom during the last sexual intercourse. 
Reported condom use was higher among participants tested through mHCT compared to 
those tested at the facilities (24.6% vs. 9.0%, p<0.0001). Condom use was higher among the 
non-brothel-based sex workers (52.6%) than among brothel-based sex workers (37.4%, 
p<0.0001) and all other risk-groups. Brothel-based sex workers were more likely to report 
≥4 sex partners in the last year (71.8%) and current genital discharge (17.0%) and ulceration 
(11.3%) than any other risk-group.
Post-test counseling
The overall post-test counseling rate was 87.7% (90.0% for participants tested through 
mHCT and 86.2% for participants tested at the facilities). Among mHCT participants, post-
test counseling increased from 66.0% between May 2005 and July 2006 to 92.0% between 
August 2006 and March 2010 as a result of switching from cold-chain dependent to cold-
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chain independent rapid tests. The greatest increase was seen for the motorcycle/taxi drivers 
and outreach community testers (174% and 83% increase, respectively).
HIV prevalence
The overall prevalence of HIV infection was 13.8%, and was significantly higher among 
those tested via mHCT than in the facilities (15.6% vs. 12.7%; p=0.0005) (Table 2). HIV 
seroprevalence was more than 20% for clients at the general outpatient department, clients 
tested at the facility through voluntary counseling and testing, non-brothel-based sex 
workers, and brothel-based sex workers. Among clients receiving HCT at the facilities, HIV 
prevalence was lower in women than men (OR=0.71; 95% CI 0.64–0.79). In contrast, for 
clients reached through mobile activities, HIV prevalence was higher among women 
compared to men (OR=4.86; 95% CI 4.35 – 5.43).
Among subjects aged 18–24 years, 14.6% of 4,859 women tested HIV-positive and 2.7% of 
2,269 men tested HIV-positive (OR=6.07; 95% CI 4.66–7.91). For participants tested 
through mHCT, the HIV prevalence was 25.2% among 18–24 females and the difference in 
age-specific prevalence was higher for females across all ranges of age (Figure 1a) and after 
excluding sex workers from the analysis (data not shown). Higher prevalence among women 
aged 18–24 was also seen for those tested in facilities. However, at approximately age 26, 
prevalence in males tested in facilities becomes higher than prevalence in females, such that 
by the 30- to 44-year age group prevalence was higher for men (Figure 1b).
History of STIs, currently having genital discharge and currently having genital ulcerations 
were associated with increased HIV prevalence for both mHCT and facility-based testing 
clients, but the strength of these associations was greater for individuals reached through 
mHCT. Women reached through mHCT reported higher rates of genital discharge (11.7%) 
and ulceration (8.0%) compared to men (2.4% and 3.7%, respectively) at the time of HIV 
testing. Reported genital discharge was associated with increased HIV prevalence for men 
(OR=2.42) and women (OR= 1.78). Having genital ulceration also increased HIV risk 
(OR=2.48 for men and OR=2.10 for women). Having used condoms during last sexual 
intercourse was associated with increased HIV infection for mHCT clients (OR=1.60, 1.43–
1.79) and facility-based HCT clients (OR=1.54, 95% CI 1.34 – 1.77).
The odds of being infected with HIV varied across levels of age, gender, and site type (Table 
3), with the highest risk among 18–24 females tested through mHCT (OR=8.96; 95% CI 
6.32–12.70). STI history, condom use at last sex, and having current genital discharge were 
still associated with increased risk for HIV infection in the mHCT groups. Furthermore, 
having been previously tested was associated with decreased risk of HIV infection for 
mHCT clients (OR=0.75; 95% CI 0.64–0.88) and for facility-based clients (OR=0.27; 95% 
CI 0.24–0.31).
Awareness of HIV care services and benefits
There were no differences in demographics, history of HIV testing, condom use, reported 
sexual behaviors or history or current symptoms of STI between 7,704 individuals included 
in the analysis after March 2007 and those excluded (data not shown). The majority of 
participants believed that HIV exists and causes AIDS (Table 4). However, fewer mHCT 
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participants than facility participants reported knowing that there are medicines used to treat 
HIV (60.8% vs. 79.8%; p=0.0001). Compared to participants tested at facilities, participants 
tested in mHCT were less likely to believe that ARVs can help people with HIV live longer 
(91.1% vs 57.3%; p<0.0001), believe that ARVs can prevent death (79.1% vs. 69.1%; 
p<0.0001), believe that ARVs are free (79.8% vs. 60.2%; p<0.0001), and believe that ARVs 
are easy to get (76.0% vs. 52.7%; p<0.0001).
Analysis of these data for MARPs only (Figure 2) showed consistency with the overall 
findings of high awareness of HIV in general, but low knowledge of the availability of 
antiretroviral therapy (ART) for most at-risk women (57.8% vs. 61.0% in men; p=0.015). 
Women were also less likely than men to believe that ARVs can help people with HIV live 
longer (71.6% vs. 77.1%; p=0.0002) or prevent death (62.0% vs. 69.7%; p<0.0001). Women 
aged 18–24 years were also less likely than men in the same age group to know that there 
were medicines available to treat HIV (64.0% vs. 69.4%; p=0.047). Relative to other women 
reached through mHCT (Figure 2), brothel-based female sex workers were least likely to be 
aware of HIV care services and benefits; 51.6% knew that there are medicines to treat HIV 
and only 43.6% believed that antiretrovirals are easy to get.
DISCUSSION
To date, there have been no reports using large-scale programmatic data to describe the 
most-at-risk populations in Nigeria in terms of the yield of HCT, risks for HIV infection and 
awareness of HIV care services. Our results provide further evidence that certain 
subpopulations in Nigeria are more affected by HIV/AIDS than others, while also 
demonstrating that, controlling for other risk factors, prior history of HIV testing is 
associated with a reduced risk of HIV-infection both for persons tested at facilities and 
through mHCT. It is becoming increasingly important to monitor the epidemic among core 
risk group within the context of prevention programs. Beyond the core risk groups, the 
clients of sex workers are highly mobile (Azuonwu, Erhabor, & Frank-Peterside, 2011) and 
are difficult to monitor with regard to HIV prevalence or sexual risk behaviour as they are 
less likely to self-identify or to congregate in locations where they can be reached using 
typical community outreach methods (Espirito Santo & Etheredge, 2002).
Female sex workers, because of their high prevalence of HIV infection and economic 
incentive to have more sexual partners, are a critical population to access with HIV 
counseling and testing and other prevention programs. Their connection to large numbers of 
men within the general population acts as a bridge to other, lower-risk groups. In this 
analysis, female sex workers were more likely than other risk groups to report recent and 
consistent condom usage, but had the lowest knowledge about HIV medicines and HIV care 
services of any risk group. Sex workers can be formal (establishment based, i.e., brothel) or 
informal and may not consider themselves to be sex workers. Our data suggest that the 
epidemic differs for brothel-based and non-brothel-based sex workers, with higher condom 
use, higher awareness of HIV care services, and lower HIV prevalence observed for the 
latter. However, higher prevalence of HIV was also associated with condom use at last sex, 
suggesting further condom distribution and education is needed. Currently, there are few or 
no projects that focus on comprehensive HIV care for specific marginalized groups. 
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Targeting such core transmission groups for HIV outreach counseling, testing and access to 
ART not only has personal health benefits, but also impacts the risk of transmission (Quinn 
et al., 2000).
The odds of being infected with HIV among women aged 18–24 was nearly 9.0 times as 
high as young men, and were more than twice as high as young women tested at facilities. 
Adolescents are often overlooked in surveillance efforts because of legal issues. However, 
they have the same if not greater needs as adults for HIV services. Due to their lack of 
experience in negotiating use of services and, in some instances, legal barriers to using them, 
services may need to be delivered in a slightly different manner. Young people account for 
over 30% of HIV cases(UNICEF, 2006), with prevalence nearly three times as high among 
15- to 24- year-old females compared to males(UNAIDS, 2008). It is important to recognize 
that most-at-risk female adolescents may not come to static service delivery points, services 
may need to be specifically targeted for them and, in many cases, provided on an outreach or 
mobile basis.
STIs are poorly recognized and inadequately treated in Nigeria, even though they constitute 
a major risk factor for HIV transmission. Prevalence of laboratory-confirmed diagnosis of 
STIs among individuals in Nigeria varied between 9.5% and 21.5% (Kehinde & Lawoyin, 
2005b; Okonofua et al., 2003), with STI/HIV co-infection ranging between 19.5% and 
54.7% (Kehinde & Lawoyin, 2005a; Okonofua, et al., 2003). After controlling for other risk 
factors, self-reported genital ulcers increased the odds of being infected with HIV by 60–
70%. Our data are based on self-reports and thus may be expected to be lower than 
previously published estimates (Clark et al., 2009), but nonetheless underscore a larger 
epidemic of STIs and an association with HIV infection in different subpopulations, 
especially high-risk women. Incorporating and linking STI testing and syndromic 
management into mHCT settings with same-day HIV rapid testing could be a more efficient 
way of reaching at-risk populations with services and treatment, but further evaluation is 
needed.
Several factors should be considered when interpreting results of this study. Interviews on 
awareness of HIV care services were collected for a subset of less than half of the total study 
participants. STI data were self-reported for symptoms and signs, and were not confirmed 
through laboratory testing. The primary objective of this study was to screen for individuals 
with acute HIV infection; therefore, study participants may have been selected for facility-
based HIV testing based on clinical symptoms or suspicion of primary HIV infection. 
Nonetheless, our findings from mHCT can be used to design and evaluate appropriate 
interventions to increase HCT utilization, STI management, and referral to HIV care for 
hard-to-reach populations.
The increasing availability of ART may provide an incentive for individuals to learn their 
HIV status. In time, this may result in larger numbers of people aware that they are HIV-
positive, even before they require medical treatment. Despite the considerable scale-up of 
HIV treatment in Nigeria, ART services are still limited to urban centers with few most-at-
risk populations having access to ARV drugs and HIV care. Most-at-risk populations are 
often the least likely to access health interventions, particularly if the health services are 
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deemed to be “unfriendly.” Results from the present study demonstrate the urgent need for 
efforts to promote strategies to identify HIV-infected members of most-at-risk-populations 
and educate and inform them about availability of HIV care services. Outreach to these 
populations, particularly through peer interventions and mobile HIV counseling and testing, 
will be of utmost importance to ensure that they are able to access prevention and HIV 
treatment as prevention services.
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Figure 1. 
Figure 1a. HIV seroprevalence among individuals tested by mobile-based HCT; Nigeria, 
May 2005–March 2010(n=9371). Modeled prevalence indicated by a solid line with dotted 
lines representing 95% confidence intervals.
Green solid line is the best-fitting second-order polynomial [−0.292 + 0.020(Age) 
− 0.0002(Age)2] for male. Red solid line is the best-fitting second-order polynomial [−0.356 
+ 0.044(Age) − 0.001(Age)2] for female. Model fitness was evaluated by R2.
Figure 1b. HIV seroprevalence among individuals tested by facility-based HCT; Nigeria, 
May 2005–March 2010 (n=10630). Modeled prevalence indicated by a solid line with dotted 
lines representing 95% confidence intervals.
Green solid line is the best-fitting second-order polynomial [−0.556 + 0.035(Age) 
− 0.0004(Age)2] for male. Red solid line is the best-fitting second-order polynomial [0.255 
− 0.012(Age) + 0.0002(Age)2] for female. Model fitness was evaluated by R2.
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Figure 2. 
Awareness of HIV care services and benefits among most at risk populations in Nigeria. P-
values with single underline are from comparisons between males and females. P-values 
with double underline are from comparison between females across risk groups.
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